Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1

A research program targeted toward the identification of expanded-spectrum nonnucleoside reverse transcriptase inhibitors which possess increased potency toward K103N-containing mutant human immunodeficiency virus (HIV) and which maintain pharmacokinetics consistent with once-a-day dosing has result...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Corbett, Jeffrey W., Ko, Soo S., Rodgers, James D., Jeffrey, Susan, Bacheler, Lee T., Klabe, Ronald M., Diamond, Sharon, Lai, Chii-Ming, Rabel, Shelley R., Saye, Jo Anne, Adams, Stephen P., Trainor, George L., Anderson, Paul S., Erickson-Viitanen, Susan K.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology (ASM) 1999
Предметы:
Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC89583/
https://ncbi.nlm.nih.gov/pubmed/10582878
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы